Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Consultation record

Consultations on document series documents

6 consultations on documents of this type.

Consultations

6 documents
  • CEI-CP-038OpenDocument series10 Jul 2026 – 07 Aug 2026

    Consultation on the draft certainty index, a cross-cutting finding aid that lists every assessed outcome in the document set by its certainty rating. The index makes it possible to see, in one place, how much of the Institute's output…

    15 submissions
  • CEI-CP-033ClosedDocument series28 Apr 2025 – 28 May 2025

    Consultation on the comparison table that presents supplier dossiers side by side. The draft table shows only fields verified from a document the Institute holds, and the consultation was principally concerned with whether a sortable table…

    14 submissions1 not accepted
  • CEI-CP-028ClosedDocument series21 Oct 2024 – 20 Dec 2024

    Consultation on the structure of the document registry: the identifier scheme, the fields carried for every document, and the way a superseded document is represented. The draft assigns a permanent identifier at first publication and never…

    9 submissions1 not accepted
  • CEI-CP-020ClosedDocument series27 Jan 2024 – 27 Mar 2024

    Consultation on the format of the supplier dossier series: what a dossier contains, in what order, and what it declines to contain. The draft fixes a common structure so that two dossiers can be read against each other, and excludes any…

    10 submissions1 not accepted
  • CEI-CP-015ClosedDocument series09 Oct 2023 – 08 Dec 2023

    Consultation on the scope and drafting conventions of the analytical and methodological standards series. The central question put was whether an Institute standard should prescribe a procedure or state the performance a determination must…

    9 submissions1 not accepted
  • CEI-CP-024ClosedDocument series09 Aug 2023 – 23 Sep 2023

    Consultation on the set of indications the Institute assesses against and the anchor outcome defined for each. The draft fixes one anchor outcome per indication so that estimates carried in different documents are estimates of the same…

    15 submissions1 not accepted
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.